Trial intelligence / Profile preview

Remifentanil PCA versus pethidine for analgesia during oocyte retrieval

NL-OMON34877Phase 4Active, not recruiting

Sponsor
Vrije University Medical Center
Start
Jun 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of remifentanil and pethidine in None, sponsored by Vrije University Medical Center. Primary endpoint: Pain during oocyte retrieval. Started Jun 2010; status: active, not recruiting.

02

Drugs

remifentanilpethidine

Beyond the preview

Go deeper on NL-OMON34877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call